tert-Butyl ((trans-4-cyanocyclohexyl)methyl)carbamate

Catalog No. :
ACLMAP736
CAS No. :
473923-79-4
Molecular Formula :
C13H22N2O2
Molecular Weight :
238.33

IUPAC Name:tert-butyl (((1r,4r)-4-cyanocyclohexyl)methyl)carbamate

tert-Butyl ((trans-4-cyanocyclohexyl)methyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$167.00Login to see priceInquiryInquiry
250mg97%$242.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl ((trans-4-cyanocyclohexyl)methyl)carbamate
IUPAC Nametert-butyl (((1r,4r)-4-cyanocyclohexyl)methyl)carbamate
MDL No.MFCD09749844
Molecular FormulaC13H22N2O2
Molecular Weight238.33
SMILESO=C(OC(C)(C)C)NC[C@H]1CC[C@H](C#N)CC1
InChI KeyKOFJDBKWKCOOLP-XYPYZODXSA-N
SynonymTRANS-4-N-BOC-AMINOMETHYL-CYCLOHEXANECARBONITRILE;trans-(4-Cyano-cyclohexylmethyl)-carbamic acid tert-butyl ester;tert-butyl (((1r,4r)-4-cyanocyclohexyl)methyl)carbamate;(4-Cyanocyclohexylmethyl)-carbamic acid tert-butyl ester and enantiomer;N-[(4-cyanocyclohexyl)methyl]carbamic acid tert-butyl ester;trans-tert-Butyl (((1r,4r)-4-cyanocyclohexyl)methyl)carbamate;tert-Butyl ((trans-4-cyanocyclohexyl)methyl)carbamate;Tert-butyl N-[(4-cyanocyclohexyl)methyl]carbamate
CAS No.473923-79-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACLMAP736 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLMAP736 route product structure diagram
    ACLMAP736473923-79-4
Inquiry

2. ACLMAP736 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLMAP736 route product structure diagram
    ACLMAP736473923-79-4
Inquiry

Comments (0)